Story perspectives

Study Reveals Mark Cuban's Pharmacy Beats Insurance Prices by 431%

10/9/2025

Summary

Story summary

A Ohio State University study compares neurologic medication costs from insurance and Mark Cuban's online pharmacy, finding direct-to-consumer prices 431% lower than insured prices.
Out-of-pocket costs for online drugs were 75% higher, though many medications showed minimal price differences.
The study analyzed 33 medications for Alzheimer's disease and multiple sclerosis, and was published in JAMA Network Open.

History

Historical Context

The U.S. has faced escalating prescription drug prices, with spending exceeding $600 billion in 2023. The Affordable Care Act of 2010 aimed to improve healthcare access, yet many Americans still struggle with affordability, as nearly 25% report difficulties in affording medications. Mark Cuban's online pharmacy, offering neurologic drugs at 431% lower prices than traditional insurance, underscores the ongoing debate over healthcare pricing models.

1 of 2

Story summary

A Ohio State University study compares neurologic medication costs from insurance and Mark Cuban's online pharmacy, finding direct-to-consumer prices 431% lower than insured prices.
Out-of-pocket costs for online drugs were 75% higher, though many medications showed minimal price differences.
The study analyzed 33 medications for Alzheimer's disease and multiple sclerosis, and was published in JAMA Network Open.

1 / 2